Home - IAVI

25 years of translating scientific discoveries
into affordable, globally accessible
public health solutions
Visit the IAVI 25 website
25 years of translating scientific discoveries
into affordable, globally accessible
public health solutions
Visit the IAVI 25 website
25 years of translating scientific discoveries
into affordable, globally accessible
public health solutions
Visit the IAVI 25 website
25 years of translating scientific discoveries
into affordable, globally accessible
public health solutions
Visit the IAVI 25 website
25 years of translating scientific discoveries
into affordable, globally accessible
public health solutions
Visit the IAVI 25 website
25 years of translating scientific discoveries
into affordable, globally accessible
public health solutions
Visit the IAVI 25 website

LATEST NEWS

Marion F. Gruber

IAVI Welcomes Marion F. Gruber as VP, Public Health & Regulatory Science

25 years of HIV vaccine research

A quarter century of reporting on the quest to develop an HIV vaccine

IAVI-Greenlight Omicron vaccine development

GreenLight & IAVI begin work on Omicron variant COVID vaccine candidate

Scientists at IAVI's DDL working on rVSV program

IAVI and BARDA partner to advance filovirus vaccine candidates

TB vaccine research - MTBVAC

IAVI & Biofabri partner to advance TB vaccine candidate into efficacy trials

eOD-GT8 immune-stimulating protein

IAVI G001 Results Confirm Germline-Targeting HIV Vaccine Approach

WHAT WE DO

What We Do

Discover

new approaches to developing vaccines and antibodies for HIV, TB, emerging infectious diseases, and neglected diseases.

Accelerate

translational and clinical research through our laboratories in the U.S., India, and the U.K.

Build Capacity

in-country for researching vaccine candidates while strengthening local public health and scientific expertise.

Partner

with industry and enlist biopharma product development skills to develop innovative products tailored to target populations.

Share

IAVI’s resources with other innovators to help the global health community as a whole succeed.

Extend

IAVI’s core capabilities to solving disease prevention and treatment challenges.

©2022 International AIDS Vaccine Initiative. International AIDS Vaccine Initiative^®, IAVI^®, and the IAVI logo^® are registered trademarks of the International AIDS Vaccine Initiative, Inc.